NCT05736016

Brief Summary

The study will test the hypothesis, that the use of medial wedge insoles in people participating in comprehensive rehabilitation between 1-6 months after total hip replacement, and not having a varus deformity of the knee or symptomatic arthrosis of the medial knee compartment, will improve patient's functioning, the symmetry of gait and stance compared to persons using sham insoles. The participants will undergo a 6-week program of in-patient rehabilitation aimed at: pharmacologic and non-pharmacologic pain management, improvement of vascular function, cardiopulmonary function, functions of skeletal muscles, range of motion and stability of peripheral joints, gait function, body position. The rehabilitation program will also address individual needs with psychotherapy and vocational therapy. The study will help to identify correlations between gait parameter change and functional improvement during the rehabilitation following THR. Study participants will be provided with individually made corrective medial wedge insoles or sham insoles and instructed to use them during gait training and everyday activities. Functional parameters will be examined at the study entry, at the end of 6 weeks of intervention, and 6 weeks following discharge.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 15, 2023

Status Verified

November 1, 2023

Enrollment Period

1.8 years

First QC Date

February 9, 2023

Last Update Submit

November 13, 2023

Conditions

Keywords

Total hip replacementGaitInsolesRehabilitation

Outcome Measures

Primary Outcomes (3)

  • Mean change from baseline in pain according to Pain Rating Scale by the British Pain Society on numeric rating scales at 12 weeks

    Pain Rating Scale by the British Pain Society, the Polish version; © The British Pain Society 2006 is a self-reported instrument assessing pain intensity (now and on average last week), distress produced by pain (now and on average last week) and interference of pain with everyday activities. The result is presented on five numeric rating scales ranging from 0 (no pain/distress/interference) to 10 (worst possible pain/distress/interference). Change: (week 12 score - baseline score)

    At baseline and on 12 week

  • Mean change from baseline in pain, stiffness, and physical functional disability according to Western Ontario and McMaster Universities - WOMAC scale on 12 weeks

    WOMAC scale is a self-reported instrument assessing pain, stiffness, and physical functional disability . The results are presented on a numeric scale between 0 (no symptoms, full physical functionning) and 96 (extremely intensive symptoms, extreme disability). Change: (week 12 score - baseline score)

    At baseline and on 12 week

  • Mean change from baseline in osteoarthritis-specific symptoms and physical functional disability according to Lequesne OA index on 12 weeks

    Lequesne OA index is a self-reported instrument assessing osteoarthritis-specific symptoms and physical functional disability. The results are presented on a numeric scale between 0 (no symptoms, full physical functioning) and 24 (extremely intensive symptoms and the worst functioning). Change: (week 12 score - baseline score)

    At baseline and on 12 week

Secondary Outcomes (38)

  • Mean change from baseline in range of motion of lower extremities on 6 weeks

    At baseline and on 6 week

  • Mean change from baseline in range of motion of lower extremities on 12 weeks

    At baseline and on 12 week

  • Mean change from baseline in voluntary gait speed on 6 weeks

    At baseline and on 6 week

  • Mean change from baseline in voluntary gait speed on 12 weeks

    At baseline and on 12 week

  • Mean change from baseline in step time symmetry on 6 weeks

    At baseline and on 6 week

  • +33 more secondary outcomes

Study Arms (2)

Active Therapy

ACTIVE COMPARATOR

Active comparator will undergo a 6-week in-patient rehabilitation aimed at: pharmacologic and non-pharmacologic pain management, improvement of vascular function, cardiopulmonary function, functions of skeletal muscles, range of motion and stability of peripheral joints, gait function, body position, with treadmill walking training being a mandatory part of the program. The rehabilitation program will also address individual needs with psychotherapy and vocational therapy. Follow-up period will be 6 weeks. For the time of the treatment and follow-up period the treatment arm will be provided with individually made corrective medial wedge insoles to be used during all therapeutic and other everyday activities.

Device: medial wedge insoles ((corrective insoles are equipped with hard 10-degree medial wedge, while sham insoles are equipped with pliable 10-degree medial wedge)

Sham Therapy

SHAM COMPARATOR

Sham comparator arm will undergo a 6-week in-patient rehabilitation aimed at: pharmacologic and non-pharmacologic pain management, improvement of vascular function, cardiopulmonary function, functions of skeletal muscles, range of motion and stability of peripheral joints, gait function, body position, with treadmill walking training being a mandatory part of the program . The rehabilitation program will also address individual needs with psychotherapy and vocational therapy. Follow-up period will be 6 weeks. For the treatment and follow-up the control arm will be provided with individually made sham insoles to be used during all therapeutic and other everyday activities.

Device: medial wedge insoles ((corrective insoles are equipped with hard 10-degree medial wedge, while sham insoles are equipped with pliable 10-degree medial wedge)

Interventions

All study participants will be instructed to use insoles for exercising, walking, and other everyday activities.

Active TherapySham Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of primary or secondary hip coxarthrosis or proxmal hip facture
  • Total Hip replacement made from posterior or lateral surgical approaches
  • Total Hip replacement made less 1-6 months prior to study entry

You may not qualify if:

  • Total Hip replacement made from anterior or anterolateral approach
  • Total Hip replacement made less than 1 month or more than 6 months prior to study entry
  • Varus knee (Q angle below 5 degrees in males and below 10 degrees in females
  • Symptomatic arthritis of medial compartment of the knee
  • Use of corrective insoles (excluding insoles for limb length discrepancy compensation)
  • Inability to walk for one minute
  • Neurologic conditions
  • History of hip prosthesis dislocation
  • Cognitive dysfunction (MoCa Score below 26)
  • Lack of shoes with a stiff heel counter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (23)

  • Hewett TE, Myer GD, Ford KR, Heidt RS Jr, Colosimo AJ, McLean SG, van den Bogert AJ, Paterno MV, Succop P. Biomechanical measures of neuromuscular control and valgus loading of the knee predict anterior cruciate ligament injury risk in female athletes: a prospective study. Am J Sports Med. 2005 Apr;33(4):492-501. doi: 10.1177/0363546504269591. Epub 2005 Feb 8.

    PMID: 15722287BACKGROUND
  • Robinson RP, Clark JE. Uncemented press-fit total hip arthroplasty using the Identifit custom-molding technique. A prospective minimum 2-year follow-up study. J Arthroplasty. 1996 Apr;11(3):247-54. doi: 10.1016/s0883-5403(96)80074-x.

    PMID: 8713902BACKGROUND
  • Mesfin A, Goddard MS, Tuakli-Wosornu YA, Khanuja HS. Total hip and knee arthroplasty in patients with hereditary multiple exostoses. Orthopedics. 2012 Dec;35(12):e1807-10. doi: 10.3928/01477447-20121120-29.

    PMID: 23218641BACKGROUND
  • Fukuchi CA, Lewinson RT, Worobets JT, Stefanyshyn DJ. Effects of Lateral and Medial Wedged Insoles on Knee and Ankle Internal Joint Moments During Walking in Healthy Men. J Am Podiatr Med Assoc. 2016 Nov;106(6):411-418. doi: 10.7547/15-077.

    PMID: 28033056BACKGROUND
  • Moretti VM, Post ZD. Surgical Approaches for Total Hip Arthroplasty. Indian J Orthop. 2017 Jul-Aug;51(4):368-376. doi: 10.4103/ortho.IJOrtho_317_16.

    PMID: 28790465BACKGROUND
  • Hertel J, Sloss BR, Earl JE. Effect of foot orthotics on quadriceps and gluteus medius electromyographic activity during selected exercises. Arch Phys Med Rehabil. 2005 Jan;86(1):26-30. doi: 10.1016/j.apmr.2004.03.029.

    PMID: 15640985BACKGROUND
  • Bird AR, Bendrups AP, Payne CB. The effect of foot wedging on electromyographic activity in the erector spinae and gluteus medius muscles during walking. Gait Posture. 2003 Oct;18(2):81-91. doi: 10.1016/s0966-6362(02)00199-6.

    PMID: 14654211BACKGROUND
  • Shaw KE, Charlton JM, Perry CKL, de Vries CM, Redekopp MJ, White JA, Hunt MA. The effects of shoe-worn insoles on gait biomechanics in people with knee osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018 Feb;52(4):238-253. doi: 10.1136/bjsports-2016-097108. Epub 2017 Jul 6.

    PMID: 28684391BACKGROUND
  • Woodland LH, Francis RS. Parameters and comparisons of the quadriceps angle of college-aged men and women in the supine and standing positions. Am J Sports Med. 1992 Mar-Apr;20(2):208-11. doi: 10.1177/036354659202000220.

    PMID: 1558251BACKGROUND
  • Tillman MD, Bauer JA, Cauraugh JH, Trimble MH. Differences in lower extremity alignment between males and females. Potential predisposing factors for knee injury. J Sports Med Phys Fitness. 2005 Sep;45(3):355-9.

    PMID: 16230987BACKGROUND
  • Shultz SJ, Nguyen AD, Windley TC, Kulas AS, Botic TL, Beynnon BD. Intratester and intertester reliability of clinical measures of lower extremity anatomic characteristics: implications for multicenter studies. Clin J Sport Med. 2006 Mar;16(2):155-61. doi: 10.1097/00042752-200603000-00012.

    PMID: 16603886BACKGROUND
  • Medina McKeon JM, Hertel J. Sex differences and representative values for 6 lower extremity alignment measures. J Athl Train. 2009 May-Jun;44(3):249-55. doi: 10.4085/1062-6050-44.3.249.

    PMID: 19478840BACKGROUND
  • Khasawneh RR, Allouh MZ, Abu-El-Rub E. Measurement of the quadriceps (Q) angle with respect to various body parameters in young Arab population. PLoS One. 2019 Jun 13;14(6):e0218387. doi: 10.1371/journal.pone.0218387. eCollection 2019.

    PMID: 31194851BACKGROUND
  • Thomas KS, Russell DM, Van Lunen BL, Colberg SR, Morrison S. The impact of speed and time on gait dynamics. Hum Mov Sci. 2017 Aug;54:320-330. doi: 10.1016/j.humov.2017.06.003. Epub 2017 Jun 19.

    PMID: 28641172BACKGROUND
  • Fryzowicz A, Dworak LB, Koczewski P. Prophylaxis of medial compartment gonarthrosis in varus knee - current state of knowledge. Arch Med Sci. 2018 Mar;14(2):454-459. doi: 10.5114/aoms.2016.57961. Epub 2016 Mar 29.

    PMID: 29593820BACKGROUND
  • Klotzbier TJ, Schott N. Cognitive-Motor Interference during Walking in Older Adults with Probable Mild Cognitive Impairment. Front Aging Neurosci. 2017 Dec 11;9:350. doi: 10.3389/fnagi.2017.00350. eCollection 2017.

    PMID: 29321738BACKGROUND
  • Gierus J, Mosiolek A, Koweszko T, Kozyra O, Wnukiewicz P, Loza B, Szulc A. [The Montreal Cognitive Assessment 7.2--Polish adaptation and research on equivalency]. Psychiatr Pol. 2015 Jan-Feb;49(1):171-9. doi: 10.12740/PP/24748. Polish.

    PMID: 25844419BACKGROUND
  • Stucki G, Sangha O, Stucki S, Michel BA, Tyndall A, Dick W, Theiler R. Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis. Osteoarthritis Cartilage. 1998 Mar;6(2):79-86. doi: 10.1053/joca.1997.0097.

    PMID: 9692062BACKGROUND
  • Mendiolagoitia L, Rodriguez MA, Crespo I, Del Valle M, Olmedillas H. Kinematic Gait Analysis After Primary Total Hip Replacement: A Systematic Review: Gait After Total Hip Replacement: A Systematic Review. Indian J Orthop. 2020 Apr 16;54(6):767-775. doi: 10.1007/s43465-020-00101-x. eCollection 2020 Nov.

    PMID: 33133399BACKGROUND
  • McCrory JL, White SC, Lifeso RM. Vertical ground reaction forces: objective measures of gait following hip arthroplasty. Gait Posture. 2001 Oct;14(2):104-9. doi: 10.1016/s0966-6362(01)00140-0.

    PMID: 11544061BACKGROUND
  • Gerhardt JJ, Rondinelli RD. Goniometric techniques for range-of-motion assessment. Phys Med Rehabil Clin N Am. 2001 Aug;12(3):507-27.

    PMID: 11478185BACKGROUND
  • Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S. Hip replacement. Lancet. 2018 Nov 3;392(10158):1662-1671. doi: 10.1016/S0140-6736(18)31777-X.

    PMID: 30496081BACKGROUND
  • Di Monaco M, Castiglioni C. Which type of exercise therapy is effective after hip arthroplasty? A systematic review of randomized controlled trials. Eur J Phys Rehabil Med. 2013 Dec;49(6):893-907, quiz 921-3. Epub 2013 Oct 30.

    PMID: 24172644BACKGROUND

MeSH Terms

Conditions

Femoral FracturesOsteonecrosisHip Dislocation

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg InjuriesBone DiseasesMusculoskeletal DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsJoint DislocationsJoint DiseasesHip Injuries

Study Officials

  • Beata Tarnacka, MD PhD

    National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

    STUDY DIRECTOR

Central Study Contacts

Piotr Tederko, MD PhD FEBPRM

CONTACT

Daniel Szewczyk, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants are provided with either active or shame medical devices. Care providers (rehabilitatin team members) and outcome assessors are not acknowledged about patiens' allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: double-blind sham-controlled single-centre randomized study
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

February 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

November 15, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification will be made published on Open Science Framework.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Immediately following publication. No end date.